HR 4640
116th Congress
House
Health
Drug safety, medical device, and laboratory regulation
Health programs administration and funding
Health technology, devices, supplies
Inflation and prices
Intellectual property
Medical research
Research and development
Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2019
Introduced: October 11, 2019
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Oct 14, 2019
Referred to the Subcommittee on Health.
Oct 11, 2019
Referred to the House Committee on Energy and Commerce.
Oct 11, 2019
Introduced in House
Plain-English summary
Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2019
This bill prohibits federal agencies and nonprofit entities that conduct federally funded health care research from providing a patent for a drug based on such research until the entity receiving the patent enters into a reasonable pricing agreement with the Department of Health and Human Services.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2